학술논문
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center
Document Type
Article
Author
Source
In: Leukemia Research . (Leukemia Research, August 2022, 119)
Subject
Language
English
ISSN
18735835
01452126
01452126